Unicycive Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Unicycive Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Unicycive Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 88.9M shares, a 173% increase year-over-year.
  • Unicycive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 24.5M shares, a 63% increase from 2022.
  • Unicycive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 15.1M shares, a 29% increase from 2021.
  • Unicycive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 11.7M shares, a 37.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 88.9M +56.3M +173% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 37.9M +22.7M +149% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 34.9M +19.7M +129% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 24.5M +9.48M +63% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 32.6M +17.6M +117% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 15.2M +206K +1.37% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 15.2M +228K +1.52% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 15.1M +3.38M +29% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 15.1M +895K +6.32% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 15M +6.26M +71.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 15M +6.43M +75% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-16
Q4 2021 11.7M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 14.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 8.77M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 8.58M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.